MedTrace Logo

PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration

NCT02779686 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2016-10-04

No results posted yet for this study

Summary

This study is being conducted to compare two different genetic tests developed to determine an individuals risk of developing serious vision threatening complications from age-related macular degeneration (ARMD).

Conditions

  • Age-Related Macular Degeneration (ARMD)

Sponsors & Collaborators

  • University of Missouri-Columbia

    lead OTHER

Principal Investigators

  • Nancy Holekamp, MD · Pepose Vision Institute

  • Mathew MacCumber, MD, PhD · Rush University Medical Center

  • Arghavan Almony, MD · University of Missouri-Columbia

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02779686 on ClinicalTrials.gov